Af­ter long de­lay fol­low­ing pa­tient death, FDA lifts tri­al hold on Ad­vax­is/As­traZeneca com­bo

The FDA has lift­ed its months-long clin­i­cal hold on an Ad­vax­is com­bo ther­a­py — first brought on by a pa­tient death in its Phase I/II tri­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.